Sign in to view content

Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss

Scott W. Cousins, MD

Video
Published 2019

Related

Safety, Tolerability, and Efficacy of Tinlarebant: 24-Month Primary Outcomes of the Phase 2 Study in Adolescent Patients With Stargardt Disease
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2024
Pradeepa Yoganathan Last Word
Pradeepa Yoganathan, MSc, MD, FRCS(C)
Annual Meeting Talks
Optimization of the Port Delivery System With Ranibizumab (PDS) Implant Insertion Procedure in the LADDER Phase 2 Trial
Mark R. Wieland, MD
Annual Meeting Talks
2019

Category: AMD-Non-Neovascular

See more